Advertisement

Supply Chain



The Food and Drug Administration Tuesday issued a final rule that updates the definition of a custom device to include new statutory requirements and procedures.

While Mylan agreed to settle its Medicaid rebate case with the federal government last week for $465 million, the drugmaker is not required to classify EpiPens as a branded drug under Medicaid's rebate program until April 2017, reports CNBC.

Samsung permanently stopped production on its Galaxy Note 7 smartphone Tuesday after issuing a recall upon reports of the device overheating and catching on fire. The recall, made last month, places a spotlight on supply-chain regulation, leaving the industry to…

Advertisement

Most Read

Advertisement
Advertisement